UnitedHealth is back and lifting other health-care stocks with it, Jim Cramer says

  • 📰 NBCLA
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 59%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

UnitedHealth’s (UNH) quality quarterly results Friday is a good sign for the broader health-care landscape, CNBC’s Jim Cramer said.

Shares of UnitedHealth rose roughly 2% on Friday to around $535 each. In a largely stronger day for the market overall, theclimbed nearly 1%, with only energy and financials performing better. It's worth noting that UNH is the highest-priced stock in theUnitedHealth"is a key component in the health-care universe, and … there will be a plethora of stocks that will trade well off this," Cramer said on is one of them — up nearly 2.

5% on Friday. Cramer's Charitable Trust, the portfolio used by the CNBC Investing Club, owns Humana shares.The company's past comments had major ripple effects for health-care stocks, dragging down fellow insurers — such as Humana — while boosting shares of many medical device makers.in July helped soothe investor angst, and Cramer suggested Friday's report offered additional assurance on medical cost trends."UNH is back," he added.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 319. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Jim Cramer praises Walgreens new CEO pick, says buy the stock 'perhaps aggressively'Tim Wentworth is the right choice to lead Walgreens (WBA) in its transition to offering more health-care services, CNBC's Jim Cramer said Wednesday.
Source: CNBC - 🏆 12. / 72 Read more »

Jim Cramer praises Walgreens new CEO pick, says buy the stock ‘perhaps aggressively'Tim Wentworth is the right choice to lead Walgreens (WBA) in its transition to offering more health-care services, CNBC’s Jim Cramer said Wednesday.
Source: NBCLA - 🏆 319. / 59 Read more »